GoodRx

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GDRX

Retrieved on: 
Jeudi, avril 25, 2024
Titan, Kroger, Advertising, Class, Plaintiff, Court, GoodRx, Pharmacy, Tobacco

WHAT TO DO NEXT: To join the GoodRx class action, go to https://rosenlegal.com/submit-form/?case_id=24355 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the GoodRx class action, go to https://rosenlegal.com/submit-form/?case_id=24355 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against GoodRx Holdings, Inc. - GDRX

Retrieved on: 
Jeudi, mai 2, 2024
Action Replay, Pharmacy, LLP, Prior, News, PBM, Complaint, Pomerantz, Court, Ext, GoodRx, Cryptocurrency

NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX).

Key Points: 
  • NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX).
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • The class action concerns whether GoodRx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

DEADLINE ALERT for GDRX, CORBF, LNC, and ADSK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Jeudi, mai 2, 2024
Investment, VUL, Kroger, Policy, Suite, OTC, Autodesk, Law, Complaint, Defendant, Bank statement, GoodRx, Lincoln National Corporation, Pharmacy, Security (finance)

LOS ANGELES, May 02, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, May 02, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • The Law Offices of Frank R. Cruz, Los Angeles

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 21, 2024 in GoodRx Lawsuit – GDRX

Retrieved on: 
Jeudi, mai 2, 2024
GoodRx, Fraud, NEXT, Pharmacy, Kroger

NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of GoodRx Holdings, Inc. (NASDAQ: GDRX).

Key Points: 
  • NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of GoodRx Holdings, Inc. (NASDAQ: GDRX).
  • Shareholders who purchased shares of GDRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
  • DEADLINE: June 21, 2024 Shareholders should not delay in registering for this class action.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GDRX

Retrieved on: 
Jeudi, avril 25, 2024
Titan, Kroger, Advertising, Class, Court, GoodRx, Pharmacy, Tobacco

WHAT TO DO NEXT: To join the GoodRx class action, go to https://rosenlegal.com/submit-form/?case_id=24355 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the GoodRx class action, go to https://rosenlegal.com/submit-form/?case_id=24355 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

GDRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead the GoodRx Class Action Lawsuit

Retrieved on: 
Mercredi, avril 24, 2024
News, Kroger, PBM, Plasma protein binding, Complaint, GoodRx, Pharmacy, SAN, Tobacco

), the GoodRx class action lawsuit charges GoodRx and certain of GoodRx’s top executives and directors with violations of the Securities Exchange Act of 1934.

Key Points: 
  • ), the GoodRx class action lawsuit charges GoodRx and certain of GoodRx’s top executives and directors with violations of the Securities Exchange Act of 1934.
  • On this news, the price of GoodRx common stock fell more than 22%, according to GoodRx class action lawsuit.
  • A lead plaintiff acts on behalf of all other class members in directing the GoodRx class action lawsuit.
  • An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the GoodRx class action lawsuit.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoodRx Holdings, Inc. - GDRX

Retrieved on: 
Mercredi, avril 24, 2024
Pharmacy, LLP, Prior, News, PBM, Pomerantz, GoodRx, Cryptocurrency

NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX).

Key Points: 
  • NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX).
  • The investigation concerns whether GoodRx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

Stockholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against GoodRx Holdings, Inc. (GDRX)

Retrieved on: 
Mercredi, avril 24, 2024
GoodRx, Complaint, LLP, Person, Plasma protein binding, Pharmacy, SAN, Kroger

SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired GoodRx Holdings, Inc. (NASDAQ: GDRX) securities between September 23, 2020 and November 8, 2022.

Key Points: 
  • SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired GoodRx Holdings, Inc. (NASDAQ: GDRX) securities between September 23, 2020 and November 8, 2022.
  • For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.
  • If you choose to take no action, you can remain an absent class member.

GOODRX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Mercredi, avril 24, 2024
Person, News, Risk, PBM, Complaint, Plasma protein binding, P.C, District court, Defendant, Court, GoodRx, Telephone, Pharmacy, Cryptocurrency

Investors have until June 21, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until June 21, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • GoodRx operates a price comparison platform for prescription drugs which, in many cases, offers consumers access to lower prices (through discount codes and coupons) for their medications.
  • Defendants further acknowledged that the Company was seeking to enter into contractual relationships with pharmacies to prevent similar disruptions from occurring in the future.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the Firm

Retrieved on: 
Mardi, avril 23, 2024
Risk, Certification, Suite, Complaint, Ethics, Pharmacy, GoodRx, Security (finance)

Investors who purchased the Company’s securities between September 23, 2020 and November 8, 2022, inclusive (the “Class Period”), are encouraged to contact the firm before June 21, 2024.

Key Points: 
  • Investors who purchased the Company’s securities between September 23, 2020 and November 8, 2022, inclusive (the “Class Period”), are encouraged to contact the firm before June 21, 2024.
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.